Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same author

Single-cell analysis of recruited ILC2 cell fate during transition from circulation to establishment of tissue residency.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Sprouty2 modulates NF-κB signaling by sequestering the phosphatase PP2Ac in LPS-stimulated macrophages.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Workshop report on inflammaging: mechanisms, markers, and intervention strategies.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

CBX7 functions as a methylation-dependent inducer of gene transcription and regulator of cytosolic signaling in lymphoid cells.

Science advances·2026
Same author

Smoking Topography, Nicotine Kinetics, and Subjective Smoking Experience of Mentholated and Non-Mentholated Heated Tobacco Products in Occasional Smokers.

Toxics·2025
Same journal

Sperm-Binding Assay Using an In Vitro 3D Model of the Mammalian Cumulus-Oocyte Complex.

Current protocols in toxicology·2020
Same journal

Using Human Primary Foreskin Fibroblasts to Study Cellular Damage and Mitochondrial Dysfunction.

Current protocols in toxicology·2020
Same journal

An Open-Globe Porcine Injury Platform for Assessing Therapeutics and Characterizing Biological Effects.

Current protocols in toxicology·2020
Same journal

A Protocol to Study Mitochondrial Function in Human Neural Progenitors and iPSC-Derived Astrocytes.

Current protocols in toxicology·2020
Same journal

Measuring Changes in Keap1-Nrf2 Protein Complex Conformation in Individual Cells by FLIM-FRET.

Current protocols in toxicology·2020
Same journal

In Vitro Evaluation of Toxicant Influences on the Immune System.

Current protocols in toxicology·2020
See all related articles

Related Experiment Video

Updated: May 23, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

CYP1B1 detection.

Rao L Divi1, Andreas Luch, Mukesh Verma

  • 1Methods and Technologies Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland, USA.

Current Protocols in Toxicology
|April 19, 2012
PubMed
Summary
This summary is machine-generated.

This study details methods to measure CYP1B1 gene expression, protein levels, and enzyme activity. A novel selective inhibitor, TMS, allows precise dissection of CYP1B1 activity from related enzymes.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Related Experiment Videos

Last Updated: May 23, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cytochrome P450 1B1 (CYP1B1) plays a crucial role in the metabolism of various xenobiotics and endogenous compounds.
  • Accurate measurement of CYP1B1 activity is essential for understanding its role in disease and drug response.
  • Existing methods struggle to selectively quantify CYP1B1 activity in the presence of highly homologous CYP1A1 and CYP1A2 enzymes.

Purpose of the Study:

  • To establish robust procedures for quantifying CYP1B1 gene expression, protein levels, and enzyme activity.
  • To develop a method for selectively measuring CYP1B1 enzyme activity, distinct from CYP1A1 and CYP1A2.
  • To introduce and validate 2,4,3',5'-Tetramethoxystilbene (TMS) as a selective inhibitor for dissecting CYP1B1 function.

Main Methods:

  • Gene expression analysis using reverse transcription quantitative real-time PCR (qRT-PCR).
  • Protein level determination via Western blotting.
  • Enzyme activity assays using 7-ethoxyresorufin substrate, incorporating TMS for selective CYP1B1 inhibition and subtractive analysis.

Main Results:

  • Established protocols for measuring CYP1B1 at the gene, protein, and activity levels.
  • Demonstrated that TMS is a potent and highly selective competitive inhibitor of CYP1B1 (IC50 for EROD: 3 nM).
  • TMS exhibits significant selectivity for CYP1B1 inhibition over CYP1A1 (~50-fold) and CYP1A2 (~520-fold), enabling precise activity measurements.

Conclusions:

  • The described methods provide comprehensive tools for evaluating CYP1B1.
  • 2,4,3',5'-Tetramethoxystilbene (TMS) is a valuable chemical tool for selectively inhibiting CYP1B1.
  • TMS facilitates the accurate dissection of CYP1B1-mediated ethoxyresorufin O-deethylase (EROD) activity from the combined activity of CYP1 family members.